Breaking News, Promotions & Moves

BioCina Names Dr. Thomas Broudy as CEO

Broudy brings 20+ years of experience in the biopharmaceutical and CDMO industries, spanning operations, business development, and strategic leadership.

Author Image

By: Charlie Sternberg

Associate Editor

Dr. Thomas Broudy.

BioCina, a pharmaceutical contract development and manufacturing organization (CDMO), has appointed Dr. Thomas Broudy as Chief Executive Officer to lead the company’s growth of its biologic drug substance and sterile drug product development and manufacturing services. Broudy brings over 20 years of experience in the biopharmaceutical and CDMO industries, spanning operations, business development, and strategic leadership. “BioCina is entering an exciting new chapter,” sa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters